Ozone treatment of combined sewer overflow (CSO) for disinfection and micropollutant control
合流下水道溢流 (CSO) 的臭氧处理用于消毒和微污染物控制
基本信息
- 批准号:520196-2017
- 负责人:
- 金额:$ 4.37万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Collaborative Research and Development Grants
- 财政年份:2018
- 资助国家:加拿大
- 起止时间:2018-01-01 至 2019-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Combined sewer systems are designed to collect stormwater runoff, domestic sewage, and industrial wastewater in the same pipe and bring it to the local wastewater treatment plant (WWTP). During heavy rain and snow storms, combined sewers receive higher than normal flows. WWTPs are unable to handle these flows that may be as much as 5 to 6 time the plant's design capacity. Therefore, a portion of the excess stormwater and untreated wastewater, also called combined sewer overflow (CSO), has to be diverted to the receiving environment with little to no treatment. The CSOs are used to alleviate the overloading of the combined sewer system to prevent sewer backups in residential and commercial buildings and local streets. However, CSOs can impact the water quality and environmental ecosystems in the receiving water bodies if they are discharged into rivers without receiving proper treatment. CSOs may contain dissolved contaminants such as pharmaceuticals and personal care products, particulate organic matter loads, bacteria and viruses. Therefore, there is an urgent need to enhance the treatment of CSOs to reduce their environmental impacts. The proposed NSERC Collaborative Research and Development (CRD) Program will conduct a comprehensive fundamental and applied research in the area of municipal wastewater, with a focus on a deep understanding of ozonation in terms of process fundamentals, treatment mechanisms, and practical applicability for CSO treatment. The overall objective of the proposed CRD Program is to develop an effective ozone-based treatment approach for the safe release of treated CSOs into the environment. Using ozonation or catalytic ozonation as disinfectant and oxidant may be a viable option to simultaneously enhance the disinfection capabilities to meet the regulatory requirements and target micropollutants that are present in CSOs. This NSERC CRD program is a major advancement in wastewater treatment by providing an enhanced ozone-based treatment approach, aiming to improve the overall quality of the discharged CSOs into the environment and promote the protection of the environment and human health in Canada.
联合下水道系统旨在将雨水径流,生活污水和工业废水收集在同一管道中,并将其带到当地的污水处理厂(WWTP)。在暴雨和暴风雪期间,综合下水道的流量高于正常水平。污水处理厂无法处理这些流量,这些流量可能是工厂设计能力的5到6倍。因此,一部分多余的雨水和未经处理的废水,也被称为联合下水道溢流(CSO),必须在几乎没有处理的情况下被转移到接收环境。市政系统的作用是减轻合用污水渠系统的超载,防止住宅、商业楼宇及本地街道的污水渠堵塞。然而,如果公民社会组织未经适当处理而排入河流,则会影响接收水体的水质和环境生态系统。公民社会组织可能含有溶解的污染物,如药品和个人护理产品、颗粒有机物质负荷、细菌和病毒。因此,迫切需要加强对民间社会组织的处理,以减少其对环境的影响。拟议的NSERC合作研究与发展(CRD)计划将在城市污水领域开展全面的基础和应用研究,重点是深入了解臭氧化在CSO处理方面的工艺基础、处理机制和实际适用性。拟议的CRD计划的总体目标是开发一种有效的基于臭氧的处理方法,使处理后的cso安全释放到环境中。使用臭氧化或催化臭氧化作为消毒剂和氧化剂可能是一种可行的选择,可以同时增强消毒能力,以满足监管要求并针对公民社会组织中存在的微污染物。NSERC的CRD方案是废水处理方面的一项重大进展,它提供了一种基于臭氧的强化处理方法,旨在提高排放到环境中的cso的总体质量,促进加拿大对环境和人类健康的保护。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GamalElDin, Mohamed其他文献
GamalElDin, Mohamed的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GamalElDin, Mohamed', 18)}}的其他基金
Application of Catalytic Oxidation for Simultaneous Adsorption and Oxidation for Municipal Wastewater Reuse and Resource Recovery
催化氧化同步吸附氧化在城市污水回用及资源化中的应用
- 批准号:
RGPIN-2018-05882 - 财政年份:2022
- 资助金额:
$ 4.37万 - 项目类别:
Discovery Grants Program - Individual
Application of Catalytic Oxidation for Simultaneous Adsorption and Oxidation for Municipal Wastewater Reuse and Resource Recovery
催化氧化同步吸附氧化在城市污水回用及资源化中的应用
- 批准号:
RGPIN-2018-05882 - 财政年份:2021
- 资助金额:
$ 4.37万 - 项目类别:
Discovery Grants Program - Individual
Coagulant-Flocculant Chemistry of SAGD Emulsion Breaker (EB) - Reverse Emulsion Breaker (REB) and Warm Lime Softener (WLS)
SAGD 破乳剂 (EB) - 反破乳剂 (REB) 和温石灰软化剂 (WLS) 的混凝剂-絮凝剂化学
- 批准号:
533279-2018 - 财政年份:2021
- 资助金额:
$ 4.37万 - 项目类别:
Collaborative Research and Development Grants
NSERC Industrial Research Chair in Oil Sands Tailings Water Treatment
NSERC 油砂尾矿水处理工业研究主席
- 批准号:
514308-2016 - 财政年份:2021
- 资助金额:
$ 4.37万 - 项目类别:
Industrial Research Chairs
Demonstration Pit Lake research & monitoring program for evaluating permanent aquatic storage structure technology & closure management for generating a self-sustaining ecosystem
示范坑湖研究
- 批准号:
543680-2019 - 财政年份:2021
- 资助金额:
$ 4.37万 - 项目类别:
Collaborative Research and Development Grants
Coagulant-Flocculant Chemistry of SAGD Emulsion Breaker (EB) - Reverse Emulsion Breaker (REB) and Warm Lime Softener (WLS)
SAGD 破乳剂 (EB) - 反破乳剂 (REB) 和温石灰软化剂 (WLS) 的混凝剂-絮凝剂化学
- 批准号:
533279-2018 - 财政年份:2020
- 资助金额:
$ 4.37万 - 项目类别:
Collaborative Research and Development Grants
Demonstration Pit Lake research & monitoring program for evaluating permanent aquatic storage structure technology & closure management for generating a self-sustaining ecosystem
示范坑湖研究
- 批准号:
543680-2019 - 财政年份:2020
- 资助金额:
$ 4.37万 - 项目类别:
Collaborative Research and Development Grants
Application of Catalytic Oxidation for Simultaneous Adsorption and Oxidation for Municipal Wastewater Reuse and Resource Recovery
催化氧化同步吸附氧化在城市污水回用及资源化中的应用
- 批准号:
RGPIN-2018-05882 - 财政年份:2020
- 资助金额:
$ 4.37万 - 项目类别:
Discovery Grants Program - Individual
NSERC Industrial Research Chair in Oil Sands Tailings Water Treatment
NSERC 油砂尾矿水处理工业研究主席
- 批准号:
514308-2016 - 财政年份:2020
- 资助金额:
$ 4.37万 - 项目类别:
Industrial Research Chairs
Demonstration Pit Lake research & monitoring program for evaluating permanent aquatic storage structure technology & closure management for generating a self-sustaining ecosystem
示范坑湖研究
- 批准号:
543680-2019 - 财政年份:2019
- 资助金额:
$ 4.37万 - 项目类别:
Collaborative Research and Development Grants
相似国自然基金
噬菌体靶向肠道粪肠球菌提高帕金森病左旋多巴疗效的机制研究
- 批准号:82371251
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
- 批准号:82371144
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
- 批准号:82373145
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
基于密度泛函理论金原子簇放射性药物设计、制备及其在肺癌诊疗中的应用研究
- 批准号:82371997
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
基于仿生矿化法构建氢离子捕获的炎症调节性水凝胶微球在卒中治疗中的研究
- 批准号:82372120
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
- 批准号:82370885
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
MICA基因及其抗体在肾移植排斥反应中的作用机制与干预策略研究
- 批准号:30872530
- 批准年份:2008
- 资助金额:33.0 万元
- 项目类别:面上项目
相似海外基金
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
- 批准号:
10481965 - 财政年份:2024
- 资助金额:
$ 4.37万 - 项目类别:
Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
- 批准号:
10752046 - 财政年份:2024
- 资助金额:
$ 4.37万 - 项目类别:
Glut1+ cancer associated fibroblasts enforce a metabolic barrier to tumor T cell infiltration
Glut1癌症相关成纤维细胞增强了肿瘤T细胞浸润的代谢屏障
- 批准号:
10752508 - 财政年份:2024
- 资助金额:
$ 4.37万 - 项目类别:
Combined treatment by different wavelengths of ultraviolet to inactivation enveloped virus
不同波长紫外线联合处理灭活包膜病毒
- 批准号:
23K14894 - 财政年份:2023
- 资助金额:
$ 4.37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
KRAS inhibitors prime cancer cells for macrophage-mediated destruction
KRAS 抑制剂可引发巨噬细胞介导的破坏癌细胞
- 批准号:
10638364 - 财政年份:2023
- 资助金额:
$ 4.37万 - 项目类别:
Dose Flexible Combination 3D-Printed Delivery Systems for Antiviral Therapy in Children
用于儿童抗病毒治疗的剂量灵活组合 3D 打印输送系统
- 批准号:
10682185 - 财政年份:2023
- 资助金额:
$ 4.37万 - 项目类别:
Elucidating the critical role of Wee1 in GIST
阐明 Wee1 在 GIST 中的关键作用
- 批准号:
10681775 - 财政年份:2023
- 资助金额:
$ 4.37万 - 项目类别:
Concurrent Aerobic Exercise and Cognitive Training to Prevent Alzheimer's in at-risk Older Adults
同时进行有氧运动和认知训练可预防高危老年人的阿尔茨海默病
- 批准号:
10696409 - 财政年份:2023
- 资助金额:
$ 4.37万 - 项目类别:
Defining the molecular and radiologic phenotype of progressive RA-ILD
定义进行性 RA-ILD 的分子和放射学表型
- 批准号:
10634344 - 财政年份:2023
- 资助金额:
$ 4.37万 - 项目类别: